elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
AID.2011.0336
AID.2011.0336
http://dx.doi.org/10.1089/AID.2011.0336
A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study.
P356
Q36250418-ACEA75E7-759A-43A9-8A0C-20B120EDAC1F
P356
AID.2011.0336
http://dx.doi.org/10.1089/AID.2011.0336